Effects of Exenatide on Hypothalamic Obesity

Summary

The primary aim of this study is to evaluate the effect of Exenatide on weight status (change in body mass index) of children treated for craniopharyngioma that have developed hypothalamic obesity at Children's Hospitals and Clinics of Minnesota. We hypothesize that Exenatide given to hypothalamic obese children for 6 months will reduce their body mass index significantly from baseline.

Timeline

Start

2010-01

Primary completion

2013-07

Completion

2019-03-15

Drugs

Indications